Format
Sort by

Send to

Choose Destination

Search results

Items: 8

1.

Effect of trelagliptin on vascular endothelial functions and serum adiponectin level in patients with type 2 diabetes: a preliminary single-arm prospective pilot study.

Ida S, Murata K, Betou K, Kobayashi C, Ishihara Y, Imataka K, Uchida A, Monguchi K, Kaneko R, Fujiwara R, Takahashi H.

Cardiovasc Diabetol. 2016 Nov 4;15(1):153.

2.

A rapid and sensitive UHPLC-MS/MS assay for the determination of trelagliptin in rat plasma and its application to a pharmacokinetic study.

Hu XX, Lan T, Chen Z, Yang CC, Tang PF, Yuan LJ, Hu GX, Cai JP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 15;1033-1034:166-71. doi: 10.1016/j.jchromb.2016.08.024.

PMID:
27561183
3.

Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism.

Grimshaw CE, Jennings A, Kamran R, Ueno H, Nishigaki N, Kosaka T, Tani A, Sano H, Kinugawa Y, Koumura E, Shi L, Takeuchi K.

PLoS One. 2016 Jun 21;11(6):e0157509. doi: 10.1371/journal.pone.0157509.

4.

Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds.

Zhang H, Sun L, Zou L, Hui W, Liu L, Zou Q, Ouyang P.

J Pharm Biomed Anal. 2016 Sep 5;128:18-27. doi: 10.1016/j.jpba.2016.04.041.

PMID:
27209451
6.

First novel once-weekly DPP-4 inhibitor, trelagliptin, for the treatment of type 2 diabetes mellitus.

Kaku K.

Expert Opin Pharmacother. 2015;16(16):2539-47. doi: 10.1517/14656566.2015.1099630. Review.

PMID:
26523434
7.

Trelagliptin: First Global Approval.

McKeage K.

Drugs. 2015 Jul;75(10):1161-4. doi: 10.1007/s40265-015-0431-9. Review.

PMID:
26115728
8.

Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study.

Inagaki N, Onouchi H, Maezawa H, Kuroda S, Kaku K.

Lancet Diabetes Endocrinol. 2015 Mar;3(3):191-7. doi: 10.1016/S2213-8587(14)70251-7.

PMID:
25609193
Items per page

Supplemental Content

Loading ...
Support Center